Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1993 1
1996 2
1997 3
1998 1
1999 3
2000 3
2001 3
2002 2
2003 2
2004 5
2005 8
2006 5
2007 5
2008 9
2009 4
2010 7
2011 11
2012 8
2013 4
2014 10
2015 9
2016 9
2017 8
2018 5
2019 1
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Radiopharmaceuticals for somatostatin receptor imaging.
Mikołajczak R, Maecke HR. Mikołajczak R, et al. Among authors: maecke hr. Nucl Med Rev Cent East Eur. 2016;19(2):126-32. doi: 10.5603/NMR.2016.0024. Nucl Med Rev Cent East Eur. 2016. PMID: 27479790 Free article. Review.
[Somatostatin receptor PET/CT (SSTR-PET/CT)].
Boy C, Poeppel T, Kotzerke J, Krause BJ, Amthauer H, Baum RP, Buchmann I, Ezziddin S, Führer D, Gabriel M, Kuwert T, Lahner H, Lauenstein T, Maecke HR, Nagarajah J, Rösch F, Scheidhauer K, Schmidt M, Walter MA, Bockisch A. Boy C, et al. Among authors: maecke hr. Nuklearmedizin. 2018 Feb;57(1):4-17. doi: 10.1055/s-0038-1636560. Epub 2018 Feb 21. Nuklearmedizin. 2018. PMID: 29536494 German.
Radiopharmaceutical development of radiolabelled peptides.
Fani M, Maecke HR. Fani M, et al. Among authors: maecke hr. Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S11-30. doi: 10.1007/s00259-011-2001-z. Eur J Nucl Med Mol Imaging. 2012. PMID: 22388624 Review.
Peptide-based probes for cancer imaging.
Reubi JC, Maecke HR. Reubi JC, et al. Among authors: maecke hr. J Nucl Med. 2008 Nov;49(11):1735-8. doi: 10.2967/jnumed.108.053041. Epub 2008 Oct 16. J Nucl Med. 2008. PMID: 18927341 Free article. Review.
Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks.
Pfestroff A, Luster M, Jilg CA, Olbert PJ, Ohlmann CH, Lassmann M, Maecke HR, Ezziddin S, Bodei L; Radionuclide Therapy Committee of the European Association of Nuclear Medicine. Pfestroff A, et al. Among authors: maecke hr. Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1971-5. doi: 10.1007/s00259-015-3186-3. Eur J Nucl Med Mol Imaging. 2015. PMID: 26373947 No abstract available.
Reply to: Appearances are often deceptive.
Boy C, Lahner H, Maecke HR, Bockisch A, Poeppel TD. Boy C, et al. Among authors: maecke hr. Nuklearmedizin. 2018 Aug;57(4):168-169. doi: 10.1055/s-0038-1668503. Epub 2018 Aug 20. Nuklearmedizin. 2018. PMID: 30125930 No abstract available.
(68)Ga-labeled peptides in tumor imaging.
Maecke HR, Hofmann M, Haberkorn U. Maecke HR, et al. J Nucl Med. 2005 Jan;46 Suppl 1:172S-8S. J Nucl Med. 2005. PMID: 15653666 Free article. Review.
Radiopeptide imaging and therapy in Europe.
Ambrosini V, Fani M, Fanti S, Forrer F, Maecke HR. Ambrosini V, et al. Among authors: maecke hr. J Nucl Med. 2011 Dec;52 Suppl 2:42S-55S. doi: 10.2967/jnumed.110.085753. J Nucl Med. 2011. PMID: 22144555 Free article. Review.
122 results